Immunic Inc. (IMUX) Misses Q2 EPS by 3c

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Mizuho Starts Sol Gel Technologies Ltd. (SLGL) at Outperform
• BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform